Catherine C. Turkel

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse et al. · Headache The Journal of Head and Face Pain · 2010 · 986 citations

Medicine, Pharmacology, Pharmacotherapy +17

Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers

Dawn C. Buse, AN Manack, Daniel Serrano et al. · Journal of Neurology Neurosurgery & Psychiatry · 2010 · 617 citations · Full text

Education, Neurology, Behavioral Epidemiology +15

Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a Stroke

Allison Brashear, Mark Forrest Gordon, Elie P. Elovic et al. · New England Journal of Medicine · 2002 · 560 citations · Full text

Medicine, Neurology, Rehabilitation Medicine +16

Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study

Dawn C. Buse, Aubrey Manack, Kristina M. Fanning et al. · Headache The Journal of Head and Face Pain · 2012 · 545 citations

Medicine, Neurology, Disability Insurance +15

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56‐Week PREEMPT Clinical Program

Sheena K. Aurora, Paul Winner, Marshall C. Freeman et al. · Headache The Journal of Head and Face Pain · 2011 · 300 citations

Medicine, Pharmacology, Pharmacotherapy +17